Inventor profile of:

LAURA CODARRI-DEAK

City:

SCHLIEREN

Country:

Switzerland

Published Applications:

18

Last publication date:

2025-11-20

Top Assignees for applications by LAURA CODARRI-DEAK

The entities that hold a legal rights for patent applications filed by inventor CODARRI-DEAK LAURA:

Recent patent applications by CODARRI-DEAK LAURA

LAURA CODARRI-DEAK from SCHLIEREN, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-20
US20250352822A1
Human necessities

COMBINATIONS AND USES THEREOF

#2 | 2025-10-09
US20250313629A1
Chemistry; metallurgy

ANTI-LAG3 ANTIBODIES

#3 | 2024-10-03
US20240327519A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING CANCER

#4 | 2024-07-04
US20240216471A1
Human necessities

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1

#5 | 2024-01-04
US20240002506A1
Chemistry; metallurgy

ANTI-LAG3 ANTIBODIES

#6 | 2023-05-04
US20230134606A1
Human necessities

Immunoconjugates

#7 | 2023-03-09
US20230071733A1
Human necessities

Immunoconjugates

#8 | 2022-12-08
US20220387586A1
Human necessities

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

#9 | 2022-08-18
US20220259314A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3

#10 | 2022-03-10
US20220072103A1
Human necessities

Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1

#11 | 2020-11-12
US20200354457A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES COMPRISING AN ANTIGEN-BINDING SITE BINDING TO LAG3

#12 | 2020-09-03
US20200277372A1
Chemistry; metallurgy

ANTI-LAG3 ANTIBODIES

#13 | 2019-10-24
US20190322748A1
Chemistry; metallurgy

Bispecific antibodies specific for PD1 and TIM3

#14 | 2019-10-17
US20190315868A1
Chemistry; metallurgy

Therapeutic and diagnostic methods for cancer

#15 | 2018-11-15
US20180326054A1
Human necessities

Bispecific antibodies specifically binding to PD1 and LAG3

#16 | 2018-11-15
US20180326011A1
Human necessities

Immunoconjugates

#17 | 2018-11-15
US20180326010A1
Human necessities

Immunoconjugates

#18 | 2017-04-27
US20170114135A1
Chemistry; metallurgy

Bispecific antibodies specific for PD1 and TIM3

InventorID:

1858017 ⎘